PET Imaging and biodistribution of chemically modified bacteriophage MS2.
about
Stealth filaments: Polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X.Virus-Based Nanoparticles as Versatile NanomachinesVirus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicineMultivalent viral capsids with internal cargo for fibrin imaging.Understanding the enormous diversity of bacteriophages: the tailed phages that infect the bacterial family EnterobacteriaceaeBacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.To Target or Not to Target: Active vs. Passive Tumor Homing of Filamentous Nanoparticles Based on Potato virus XSynthetically Modified Viral Capsids as Versatile Carriers for Use in Antibody-Based Cell Targeting.Detection and imaging of aggressive cancer cells using an epidermal growth factor receptor (EGFR)-targeted filamentous plant virus-based nanoparticle.Design of virus-based nanomaterials for medicine, biotechnology, and energy.Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in miceProduction and applications of engineered viral capsids.Functionalization of protein-based nanocages for drug delivery applications.Viral chemistry: the chemical functionalization of viral architectures to create new technology.Plant viral and bacteriophage delivery of nucleic acid therapeutics.In Vivo Evaluation of Site-Specifically PEGylated Chemically Self-Assembled Protein NanostructuresVirus-templated FRET platform for the rational design of ratiometric fluorescent nanosensors.In Vivo Bacteriophage Biodistribution.Metal ion assisted interface re-engineering of a ferritin nanocage for enhanced biofunctions and cancer therapy.Virus-like particles: Next-generation nanoparticles for targeted therapeutic delivery.Quantitative characterization of all single amino acid variants of a viral capsid-based drug delivery vehicle.
P2860
Q27334548-691D0968-B13F-4A0A-8677-9B47D190C9CCQ28068538-75734EF7-9015-48F2-9B55-8BDD7847F95BQ28550482-B606CF49-C8C4-4174-9D4B-2B0DE51E753DQ33800320-C358954D-E3F8-407D-82D8-2CD0588B9328Q34995724-B5E4C37E-5EF4-43D6-A8C8-D39F26EF1379Q35963673-22A5597F-FCA5-4FEE-8774-955DFB878AD1Q35967955-E969FE86-6EBC-40EE-84F3-6D94C0D79604Q36592213-107FECBF-923B-4D20-815A-0CA330888B79Q36879532-471B3323-2DBA-4589-B25F-E6CE61E02333Q37346447-10788FC0-E003-45E0-99D2-B74DC60F2321Q37531135-2EE4C89A-99E3-4356-A61A-CEFDEC9C506BQ38210894-8DF6D779-B047-438D-8F27-E16DD4139FCEQ38214775-10E574F6-1948-49F1-AA44-2D2729AE4D59Q38668484-45E248D4-B635-40C0-971F-C8E368995B4DQ39441748-DF498822-CD28-4B47-A8FF-2E7B9527F17BQ41502965-3D93E6CC-B350-4A42-9565-634FF3C61206Q41716219-D9356220-5362-48BA-8DAA-8ED800AAF2F3Q43033569-E078009C-0178-4689-A15D-DADAB275DB20Q47225124-7F9671ED-D1C5-4D23-AB99-EBE1A70010BEQ54290026-1AE9E57E-229D-44B8-A899-B0C54AFEE4EBQ55251922-A21AEAFA-14D7-467B-AA1B-2D45AC8845FC
P2860
PET Imaging and biodistribution of chemically modified bacteriophage MS2.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
PET Imaging and biodistribution of chemically modified bacteriophage MS2.
@en
PET Imaging and biodistribution of chemically modified bacteriophage MS2.
@nl
type
label
PET Imaging and biodistribution of chemically modified bacteriophage MS2.
@en
PET Imaging and biodistribution of chemically modified bacteriophage MS2.
@nl
prefLabel
PET Imaging and biodistribution of chemically modified bacteriophage MS2.
@en
PET Imaging and biodistribution of chemically modified bacteriophage MS2.
@nl
P2093
P356
P1476
PET Imaging and biodistribution of chemically modified bacteriophage MS2.
@en
P2093
Christopher R Behrens
Gary J Tong
Ioana L Aanei
James P O'Neil
Matthew B Francis
Michelle E Farkas
Stephanie T Murphy
P356
10.1021/MP3003754
P407
P577
2012-12-26T00:00:00Z